Skip to main content

FLUORESCITE

Generic: fluorescein sodium

Data may be stale·Apr 23, 2026
Manufacturer
Alcon
NDC
0065-0092
Route
OPHTHALMIC
ICD-10 indication
H35.04

Affordability Check

How much will you actually pay for FLUORESCITE?

In 30 seconds, see every legitimate way to afford FLUORESCITE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About FLUORESCITE

What is this medication?

Fluorescite is a prescription medication containing the active ingredient fluorescein sodium, which functions as a diagnostic coloring agent. It is typically administered by a healthcare professional through an intravenous injection into a vein in the arm. The medication is used to facilitate a diagnostic procedure known as fluorescein angiography, which provides a clear view of the blood vessels located in the retina and the iris.

As the dye travels through the circulatory system and into the eye, it glows under specific wavelengths of light. This allows specialized cameras to capture detailed images of the ocular blood flow. Doctors use these images to detect abnormalities, such as blockages, leakages, or the development of new, fragile blood vessels often associated with conditions like macular degeneration or diabetic retinopathy.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for FLUORESCITE. Official source: DailyMed (NLM) · Label effective Dec 23, 2019

Indications and usage
INDICATIONS For testing tear film stability by determining the fluorescein break-up time (FBUT).
Dosage and administration
DIRECTIONS FOR USE Procedure for measuring Fluorescein Break-up Time (FBUT) with Amcon Dry Eye Test Strips. 1. Apply one or two drops of non-preserved saline to the impregnated paper tip. Excess fluid will automatically fall off. Shaking is neither required nor desirable. 2. Ask the patient to look down and in. 3. Gently touch the strip to the superior temporal bulbar conjunctiva for one or two seconds. 4. Ask the patient to blink three times and open eyes naturally. 5. Conduct the FBUT measurements immediately. 6. Perform two consecutive measurements. If not consistent, conduct a third and average the results. 7. Repeat steps 1 through 6 using a new strip for the second eye FBUT values of less than 10 seconds are considered abnormal. Values less than 5 seconds are indicative of dry eye disorder. Values of 5 to 9 seconds are borderline dry eye. NOTE: The contents may not be sterile if the individual strip package has been damaged or previously opened. This product is intended for external use only. Keep out of reach of children. Store below 30°C.
Contraindications
CONTRAINDICATIONS Hypersensitivity to components or mercury-containing compounds.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.